Metformin + low-dose rosiglitazone better than placebo in delaying onset of DM in pts with IGT (CANOE)

Metformin + low-dose rosiglitazone better than placebo in delaying onset of DM in pts with IGT (CANOE) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Metformin + low-dose rosiglitazone better than placebo in delaying onset of DM in pts with IGT (CANOE) ID - 427090 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427090/all/Metformin_+_low_dose_rosiglitazone_better_than_placebo_in_delaying_onset_of_DM_in_pts_with_IGT__CANOE_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -